BLFS
Biolife Solutions
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: BLFS
- PE Ratio
The PE ratio for Biolife Solutions stock stands at 31.71 as of Sep 23, 2026. This results from the current EPS of $1.19 and stock price of $37.74.
BLFS PE ratio history
Over the last eight years, the average PE ratio of Biolife Solutions has been 378.99. The current 31.71 PE ratio is 92% below the historical average. In the past eight years, BLFS's PE ratio was at its highest in the Jun 2021 quarter at 1,483.67, with a price of $44.51 and an EPS of $0.03. The Mar 2020 quarter recorded the bottom point at 5.86, with a price of $9.5 and an EPS of $1.62.
Biolife Solutions PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $24.18 | -$0.09 |
| 2024 | N/A | N/A | $25.96 | -$0.44 |
| 2023 | N/A | N/A | $16.25 | -$1.55 |
| 2022 | N/A | N/A | $18.2 | -$3.29 |
| 2021 | N/A | N/A | $37.27 | -$0.23 |
| 2020 | 569.86 | N/A | $39.89 | $0.07 |
| 2019 | N/A | N/A | $16.18 | -$0.09 |
| 2018 | N/A | N/A | $12.03 | -$1.56 |
| 2017 | N/A | N/A | $6 | -$0.21 |
| 2016 | N/A | N/A | $1.61 | -$0.54 |
| 2015 | N/A | N/A | $2.17 | -$0.35 |
| 2014 | N/A | N/A | $1.64 | -$0.31 |
| 2013 | N/A | N/A | $8.4 | -$0.22 |
| 2012 | N/A | N/A | $4.76 | -$0.33 |
| 2011 | N/A | N/A | $0.7 | -$0.42 |
Biolife Solutions PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 23.73 | N/A | $28.24 | $1.19 |
| Mar 2026 | N/A | N/A | $19.08 | -$0.06 |
| Dec 2025 | N/A | N/A | $24.18 | -$0.09 |
| Sep 2025 | N/A | N/A | $25.51 | -$0.06 |
| Jun 2025 | N/A | N/A | $21.54 | -$0.11 |
| Mar 2025 | N/A | N/A | $22.84 | -$0.23 |
| Dec 2024 | N/A | N/A | $25.96 | -$0.44 |
| Sep 2024 | N/A | N/A | $25.04 | -$1.57 |
| Jun 2024 | N/A | N/A | $21.43 | -$1.89 |
| Mar 2024 | N/A | N/A | $18.55 | -$1.56 |
| Dec 2023 | N/A | N/A | $16.25 | -$1.55 |
| Sep 2023 | N/A | N/A | $13.81 | -$1.95 |
| Jun 2023 | N/A | N/A | $22.1 | -$1.83 |
| Mar 2023 | N/A | N/A | $21.75 | -$3.43 |
| Dec 2022 | N/A | N/A | $18.2 | -$3.29 |
BLFS Price vs fair value
BLFS average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of BLFS is lower than the 10-year average.
PE comparison
Biolife Solutions's P/E of 31.71 is above the Healthcare sector average but below the industry average. Compared to its Healthcare sector average of 23.69, Biolife Solutions's P/E is 34% higher.
BLFS PE vs peers
Frequently asked questions
What is Biolife Solutions's PE ratio?
BLFS's price to earnings ratio is 31.71 as of Sep 23, 2026.
What is the highest PE ratio for BLFS?
In the last eight years, the Jun 2021 quarter recorded the highest quarterly PE ratio at 1,483.67.
How does the current PE ratio for BLFS compare to its historical average?
BLFS's price to earnings ratio is currently 92% below its 8-year historical average.
How is BLFS's PE ratio calculated (Biolife Solutions PE ratio formula)?
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Sep 23, 2026), Biolife Solutions's stock price is $37.74. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $1.19. Therefore, Biolife Solutions's P/E ratio for today is 31.71. PE RATIO(31.71) = STOCK PRICE($37.74) / TTM EPS($1.19)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.